News · 26 weeks78+50%
2026-03-012026-08-23
Mix2390d
- Insider9(39%)
- Other6(26%)
- SEC Filings3(13%)
- Analyst3(13%)
- Earnings1(4%)
- Dividends1(4%)
Latest news
25 items- INSIDERDirector Stryker Ronda E sold $117,776,128 worth of shares (350,000 units at $336.50) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDEROfficer King Debra sold $277,787 worth of shares (826 units at $336.30), decreasing direct ownership by 12% to 6,210 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- ANALYSTStryker downgraded by Wolfe ResearchWolfe Research downgraded Stryker from Outperform to Peer Perform
- PRProvidence™ Medical Technology Appoints Lane Major as President & Chief Executive OfficerAppointment builds on Providence's category leadership in Total Segmental Fusion (TSF)PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Providence Medical Technology, Inc., an innovator in differentiated spinal fusion technologies designed to improve patient outcomes, today announced that its Board of Directors has appointed Lane Major as President & Chief Executive Officer. Major also joins the company's Board of Directors. The appointment comes during a period of strong commercial momentum for Providence. Adoption of the flagship CORUS™ tissue-sparing fusion technology continues to grow across both the cervical and lumbar fusi
- PRStryker declares an $0.88 per share quarterly dividendPortage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150
- INSIDERVP, Chief Comm. Officer Montagnino Kimberly Ann covered exercise/tax liability with 155 shares, decreasing direct ownership by 8% to 1,717 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDEROfficer King Debra covered exercise/tax liability with 533 shares, decreasing direct ownership by 7% to 7,036 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief Legal Officer Fletcher Robert S covered exercise/tax liability with 94 shares, decreasing direct ownership by 0.89% to 10,488 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERVP, Chief HR Officer Fink M Kathryn covered exercise/tax liability with 111 shares, decreasing direct ownership by 0.84% to 13,027 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- SECSEC Form 10-Q filed by Stryker Corporation10-Q - STRYKER CORP (0000310764) (Filer)
- SECStryker Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - STRYKER CORP (0000310764) (Filer)
- PRStryker reports second quarter 2026 operating resultsPortage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased 9.4% to $6.6 billionOrganic net sales increased 9.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 170 bps to 27.4%Reported EPS increased 44.1% to $3.30Adjusted EPS(1) increased 17.9% to $3.69 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology 9.7 % 0.5 % 9.2 % — % 9.2 %Orthopaedics 9
- ANALYSTUBS resumed coverage on Stryker with a new price targetUBS resumed coverage of Stryker with a rating of Buy and set a new price target of $400.00
- PRStryker expands Mako robotics portfolio with full market release of Mako RPSNew handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic marketStryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures.The launch introduces Mako Handheld Robotics, expanding the Mako portfolio beyond robotic-arm assisted surgery.Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.PORTAGE, Mich., July 16, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement pro
- ANALYSTBMO Capital Markets initiated coverage on Stryker with a new price targetBMO Capital Markets initiated coverage of Stryker with a rating of Outperform and set a new price target of $369.00
- PRStryker to announce second quarter 2026 financial resultsPortage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast. About Stryker Stryker is a global leader in medical technologies and
- SECStryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - STRYKER CORP (0000310764) (Filer)
- PRStryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacementPORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand ambassador for its Joint Replacement division. Through this collaboration, Lowry will share a deeply personal story, highlighting the critical role caregivers play in supporting loved ones through joint pain, surgery and recovery. As a caregiver to his father, Brendan, a former Gaelic football p
- PRFresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma FirepowerIssued on behalf of Conexeu Sciences Inc.A clutch of new directors with Fortune 500 finance, M&A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization — in one of medicine's most consequential frontiers.RENO, Nev., June 16, 2026 /CNW/ -- American News Group News Commentary — There is a well-worn pattern in the life sciences: a company spends years on the science, goes public, and then — in the critical window right after listing — races to assemble the kind of leadership bench that can turn a promising platform into a real business. The names a young company recruits in that window say a great deal about its ambitions. On June 1
- INSIDERPresident and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker launches TPX HD® power tool, supporting demanding orthopaedic proceduresPORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures. "Revision procedures are some of the most demanding cases surgeons face, especially when metal cutting is involved," said Mike Carlin, president of Stryker's Ortho Tech division. "TPX HD was designed with tho
- INSIDERVP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- INSIDERDirector Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)4 - STRYKER CORP (0000310764) (Issuer)
- PRStryker Launches Pangea Plating System and Completes First Case in EuropeStryker (NYSE:SYK), a global leader in medical technologies, announced today the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns. Prof. Alex Trompeter, design surgeon and orthopaedic trauma surgeon, along with his team at St. George's University Hospital in London, completed the first clinical case in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525326817/en/Stryker's Pangea Plating System brings together thoughtfully designed plates and a streamlined instrumentation set, giving surgeons practical options when treating a range of fractures. "Pan
- SECSEC Form SD filed by Stryker CorporationSD - STRYKER CORP (0000310764) (Filer)
SYK FAQ
7 questionsWhat does Stryker Corporation do?
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various...Where does SYK stock trade?
Stryker Corporation (SYK) is listed on NYSE.What sector and industry is SYK in?
Stryker Corporation operates in the Health Care sector, Medical/Dental Instruments industry.Does SYK pay a dividend?
Yes. SYK's next ex-dividend date is 2026-09-30 with a declared cash dividend of $0.88 per share, payable 2026-10-30.What are analysts saying about SYK?
Stryker Corporation has had 8 recent analyst actions on file. The most recent action was from Wolfe Research: Peer Perform on 2026-08-13.What companies are similar to SYK?
Notable peers in the same industry include JNJ (Johnson & Johnson), MDT (Medtronic plc.), BDX (Becton Dickinson and Company), ZBH (Zimmer Biomet Holdings Inc.), BAX (Baxter International Inc.). Compare SYK side-by-side with any of them on Quantisnow.How can I track SYK on Quantisnow?
Quantisnow aggregates Stryker Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SYK to receive live email and push alerts on every new disclosure.